Press Releases Raffles Reports Revenue of S$199.5M and PAT of S$38.3M October 31, 2022 Raffles Medical Group and NalaGenetics Provide Pre-emptive Genetic Testing for Adverse Drug Reactions October 3, 2022 Condensed Interim Financial Statements for the Six Months Ended 30 June 2022 August 1, 2022 Raffles Reports Revenue of S$382.3M and PAT of S$60M; Opening of In-Vitro Fertilisation/Assisted Reproductive Therapy Centre at Le Cheng, Hainan August 1, 2022 Full Year Financial Statement and Related Announcement For The Year Ended 31 December 2021 February 21, 2022 Raffles Medical Group Reports Record Revenue of S$723.8 Million and Profit After Tax of S$83.7 Million February 21, 2022 Raffles Hospital Joins Hands with Myongji Hospital to Provide Travellers with a ‘Travel Medicine Pass’ Between Singapore and South Korea December 13, 2021 Raffles Medical Group Leads in Booster Jab Campaign October 12, 2021 Raffles Medical Group Conducts PCR Testing for Vaccinated Travel Lane Travellers September 13, 2021 Condensed Interim Financial Statements for the six months ended 30 June 2021 July 26, 2021 « Previous 1 2 3 4 … 23 Next » Search by Title Search by Date
Raffles Medical Group and NalaGenetics Provide Pre-emptive Genetic Testing for Adverse Drug Reactions October 3, 2022
Raffles Reports Revenue of S$382.3M and PAT of S$60M; Opening of In-Vitro Fertilisation/Assisted Reproductive Therapy Centre at Le Cheng, Hainan August 1, 2022
Full Year Financial Statement and Related Announcement For The Year Ended 31 December 2021 February 21, 2022
Raffles Medical Group Reports Record Revenue of S$723.8 Million and Profit After Tax of S$83.7 Million February 21, 2022
Raffles Hospital Joins Hands with Myongji Hospital to Provide Travellers with a ‘Travel Medicine Pass’ Between Singapore and South Korea December 13, 2021
